🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
The purpose of this study is to assess if adding revumenib to standard chem...
Status
Recruiting
Location
Clinical Trial Site
Start Date
2025-11-25
Trial ID
NCT07211958
Treatments Being Tested
This open-label Phase I study is designed to determine the maximum tolerate...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2009-06-02
Trial ID
NCT00875693
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Algemeen Ziekenhuis Middelheim
Start Date
1993-03
Trial ID
NCT00002517
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
Advances in the biological characterization of AML can now make a proper es...
Status
Unknown
Location
Hospital La Fe
Start Date
2010-12
Trial ID
NCT01296178
Treatments Being Tested
The current understanding of acute myeloid leukemia (AML) is that one site ...
Status
Unknown
Location
Juravinski Hospital and Cancer Center
Start Date
2016-04
Trial ID
NCT02682732
Treatments Being Tested
This phase II/III trial studies how well daunorubicin and cytarabine with o...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2019-03-28
Trial ID
NCT03701308
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
MRD driven study. Addition of gemtuzumab to conventional chemotherapy to re...
Status
Recruiting
Location
A.O. - SS. Antonio e Biagio e Cesare Arrigo - SC Ematologia
Start Date
2020-09-24
Trial ID
NCT04168502
Treatments Being Tested